Lys128

Site Information
sIGDTAkkLGEMWsE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 36313665
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:	gastric cancer ( 3 ) , lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 , 4 ) , non-small cell lung adenocarcinoma ( 1 ) , non-small cell large cell lung carcinoma ( 1 ) , non-small cell squamous cell lung carcinoma ( 4 ) , small-cell lung cancer ( 2 )
Relevant cell line - cell type - tissue:	DMS79 (pulmonary) ( 2 ) , HCC78 (pulmonary) ( 1 ) , lung ( 1 , 2 ) , MKN-45 (gastric) ( 3 ) , NCI-H128 (pulmonary) ( 2 ) , NCI-H1417 (pulmonary) ( 2 ) , NCI-H1703 (squamous) ( 4 ) , NCI-H1781 (pulmonary) ( 1 ) , NCI-H209 (pulmonary) ( 2 ) , NCI-H2228 (pulmonary) ( 1 ) , NCI-H3122 (pulmonary) ( 1 ) , NCI-H524 (pulmonary) ( 2 ) , NCI-H661 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20219; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20213; Year: 2013; Biosample/Treatment: cell line, H1417, DMS79, H128, H209, H524; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2012) CST Curation Set: 16030; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
4	Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info